The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis Academic Article uri icon

Overview

MeSH Major

  • Interferon-alpha
  • Polyethylene Glycols
  • Primary Myelofibrosis

abstract

  • Early treatment with rIFNα in patients without HMR mutations may prevent the development of marked splenomegaly, anemia, and florid myelofibrosis. Molecular profiling at the time of diagnosis may predict prognosis and treatment response. Cancer 2017;123:2680-87. © 2017 American Cancer Society.

publication date

  • July 15, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.30679

PubMed ID

  • 28518222

Additional Document Info

start page

  • 2680

end page

  • 2687

volume

  • 123

number

  • 14